Silodosin | Annual Sales Report

Medlab Asia & Asia Health

Not Confirmed

U.S.A

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Allergan

Silodosin

Main Therapeutic Indication : Renal Disorders

Currency : USD

2017 Revenue in Millions : 115

2016 Revenue in Millions : 122

Growth (%) : -6

Portfolio PDF

Product Web Link

Corporate PDF

02 Brand Name : Rapaflo

Medlab Asia & Asia Health

Not Confirmed

U.S.A

Allergan

Silodosin

Main Therapeutic Indication : Renal Disorders

Currency : USD

2018 Revenue in Millions : 88

2017 Revenue in Millions : 115

Growth (%) : -23%

Portfolio PDF

Product Web Link

Corporate PDF

03 Brand Name : Rapaflo

Medlab Asia & Asia Health

Not Confirmed

U.S.A

Allergan

Silodosin

Main Therapeutic Indication : Renal Disorders

Currency : USD

2016 Revenue in Millions : 122

2015 Revenue in Millions : 126

Growth (%) : -3

Portfolio PDF

Product Web Link

Corporate PDF

04 Brand Name : Rapaflo

Medlab Asia & Asia Health

Not Confirmed

U.S.A

Allergan

Silodosin

Main Therapeutic Indication : Nephrology

Currency : USD

2019 Revenue in Millions : 30

2018 Revenue in Millions : 88

Growth (%) : -67

Portfolio PDF

Product Web Link